GSK, Vir Seek Approval for COVID-19 Antibody Therapy as Shot in Arm

Published on January 13, 2022

GSK and Vir Biotechnology said on Thursday they are seeking an expansion to the U.S. approval of their antibody-based COVID-19 treatment to include an option for the therapy to be given as a shot in the arm. The drug, sotrovimab, was authorized for emergency use in the…

Read Full Article (External Site)